Loading...
XJPX
2264
Market cap2.14bUSD
Oct 09, Last price  
1,038.50JPY
1D
-0.72%
1Q
-17.45%
Jan 2017
-75.33%
Name

Morinaga Milk Industry Co Ltd

Chart & performance

D1W1MN
XJPX:2264 chart
P/E
14.83
P/S
0.59
EPS
70.01
Div yield, %
2.15%
Shrs. gr., 5y
27.02%
Rev. gr., 5y
-0.42%
Revenues
571.46b
+1.83%
578,257,000,000586,848,000,000583,910,000,000585,116,000,000583,019,000,000578,299,000,000591,197,000,000599,273,000,000594,834,000,000601,499,000,000592,617,000,000592,087,000,000583,582,000,000590,892,000,000583,550,000,000503,354,000,000525,603,000,000547,059,000,000561,173,000,000571,458,000,000
Net income
22.60b
+313.98%
5,329,000,0002,064,000,0004,254,000,0008,017,000,0006,164,000,0004,608,000,0005,016,000,0004,839,000,0004,164,000,00010,576,000,00013,202,000,00015,781,000,00014,017,000,00018,656,000,00018,741,000,00033,782,000,00016,875,000,00061,307,000,0005,459,000,00022,599,000,000
CFO
35.72b
P
27,832,000,00018,216,000,00031,333,000,00029,497,000,00030,913,000,00023,342,000,00021,055,000,00021,946,000,0008,543,000,00028,223,000,00037,349,000,00025,110,000,00018,506,000,00029,209,000,00038,544,000,00040,268,000,00019,382,000,00056,583,000,000-12,456,000,00035,716,000,000
Dividend
Mar 30, 202713 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating both domestically in Japan and across global markets, Morinaga Milk Industry Co., Ltd., along with its affiliated companies, specializes in the production and distribution of a wide array of dairy goods. Its extensive product portfolio encompasses staple dairy items like milk, yogurt, cheese, and butter. Beyond these, it extends to include chilled sweet treats, frozen desserts, specialized nutrition such as infant formulas and baby foods, health-focused dietary supplements, and dietary products for medical or elderly care. The beverage segment features a variety of milk-based drinks, coffee concoctions, and refreshing chilled teas. Furthermore, Morinaga supplies creaming powders, condensed milks, and even TOFU products. The firm also provides key ingredients for infant and toddler nutrition, specifically whey protein concentrate, lactose, and lactoferrin. Its operations additionally span the processing and packaging of various items, notably tofu and other soy-derived goods. Furthermore, Morinaga manages direct-to-consumer sales of health supplements and offers equipment for hygiene control. Established in 1917, the company, originally named Nippon Rennyu Co., Ltd. until its rebranding in 1949, maintains its corporate headquarters in Tokyo, Japan.

Related entities

Subsidiaries
MILEI Gesellschaft mit beschrankter Haftung

Key people

Yoichi Onuki
President, Representative Director · since 2021
Tsuyoshi Minato
Senior Managing Executive Officer · since 2025
Hitoshi Hyodo
Managing Executive Officer, Chief Director of Sales, Director · since 2023
Akihiro Nozaki
Managing Executive Officer, Chief Director of Finance, Director · since 2025
Yasuhiko Yanagida
Managing Executive Officer, Chief Director of Production, Director · since 2023
Hiroko Kuno
Managing Executive Officer, Chief Director of Corporate Strategy, Director · since 2025
Independent Director · since 2022
Hiroshi Nakamura
Independent Director · since 2022
Yukiko Takatori
Independent Director · since 2025
Yukari Tominaga
Independent Director · since 2020
Yasuyuki Yoshinaga
Independent Director · since 2023
IPO date
Sep 01, 1954
Employees
7,040
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
港区東新橋1丁目5番2号
東京都, 13 105-7122
JP
Other language
Morinaga Milk Industry Co., Ltd.

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT